173 related articles for article (PubMed ID: 23559676)
1. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial.
Bacchetta J; Wesseling-Perry K; Kuizon B; Pereira RC; Gales B; Wang HJ; Elashoff R; Salusky IB
Clin J Am Soc Nephrol; 2013 May; 8(5):824-32. PubMed ID: 23559676
[TBL] [Abstract][Full Text] [Related]
2. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism.
Wesseling-Perry K; Pereira RC; Sahney S; Gales B; Wang HJ; Elashoff R; Jüppner H; Salusky IB
Kidney Int; 2011 Jan; 79(1):112-9. PubMed ID: 20861820
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between osteocalcin and bone histomorphometry in children with chronic renal failure].
Weglarska J; Ziółkowska H; Pańczyk-Tomaszewska M; Sieniawska M
Pediatr Pol; 1995 Dec; 70(12):1011-5. PubMed ID: 8649939
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density, bone metabolism and body composition of children with chronic renal failure, with and without growth hormone treatment.
Boot AM; Nauta J; de Jong MC; Groothoff JW; Lilien MR; van Wijk JA; Kist-van Holthe JE; Hokken-Koelega AC; Pols HA; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 1998 Nov; 49(5):665-72. PubMed ID: 10197084
[TBL] [Abstract][Full Text] [Related]
5. 25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy.
Coen G; Mantella D; Manni M; Balducci A; Nofroni I; Sardella D; Ballanti P; Bonucci E
Kidney Int; 2005 Oct; 68(4):1840-8. PubMed ID: 16164662
[TBL] [Abstract][Full Text] [Related]
6. Value of the new bone classification system in pediatric renal osteodystrophy.
Bakkaloglu SA; Wesseling-Perry K; Pereira RC; Gales B; Wang HJ; Elashoff RM; Salusky IB
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1860-6. PubMed ID: 20634327
[TBL] [Abstract][Full Text] [Related]
7. Serum markers of low-turnover bone disease in Mexican children with chronic kidney disease undergoing dialysis.
Avila-Díaz M; Matos M; García-López E; Prado MD; Castro-Vázquez F; Ventura MD; González E; Amato D; Paniagua R
Perit Dial Int; 2006; 26(1):78-84. PubMed ID: 16538879
[TBL] [Abstract][Full Text] [Related]
8. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels.
Gal-Moscovici A; Popovtzer MM
Clin Nephrol; 2005 Apr; 63(4):284-9. PubMed ID: 15847255
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed.
Ferreira MA
Nephrol Dial Transplant; 2000; 15 Suppl 5():8-14. PubMed ID: 11073268
[No Abstract] [Full Text] [Related]
10. Racial-ethnic differences in chronic kidney disease-mineral bone disorder in youth on dialysis.
Laster M; Soohoo M; Streja E; Elashoff R; Jernigan S; Langman CB; Norris KC; Salusky IB; Kalantar-Zadeh K
Pediatr Nephrol; 2019 Jan; 34(1):107-115. PubMed ID: 30267239
[TBL] [Abstract][Full Text] [Related]
11. Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors.
Swolin-Eide D; Andersson B; Hellgren G; Magnusson P; Albertsson-Wikland K
Bone; 2018 Nov; 116():144-153. PubMed ID: 30071306
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol oral pulse therapy in children with renal osteodystrophy.
Cano F; Delucchi A; Wolff E; Rodriguez E; Fuentes A
Pediatr Nephrol; 1995 Oct; 9(5):606-8. PubMed ID: 8580020
[TBL] [Abstract][Full Text] [Related]
13. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone and the skeleton in pediatric renal allograft recipients.
Sanchez CP; Kuizon BD; Goodman WG; Gales B; Ettenger RB; Boechat MI; Wang Y; Elashoff R; Salusky IB
Pediatr Nephrol; 2002 May; 17(5):322-8. PubMed ID: 12042887
[TBL] [Abstract][Full Text] [Related]
15. Conversion from Intravenous Vitamin D Analogs to Oral Calcitriol in Patients Receiving Maintenance Hemodialysis.
Thadhani RI; Rosen S; Ofsthun NJ; Usvyat LA; Dalrymple LS; Maddux FW; Hymes JL
Clin J Am Soc Nephrol; 2020 Mar; 15(3):384-391. PubMed ID: 32111702
[TBL] [Abstract][Full Text] [Related]
16. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis.
Wesseling-Perry K; Pereira RC; Wang H; Elashoff RM; Sahney S; Gales B; Jüppner H; Salusky IB
J Clin Endocrinol Metab; 2009 Feb; 94(2):511-7. PubMed ID: 19050056
[TBL] [Abstract][Full Text] [Related]
17. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency.
Hokken-Koelega A; Mulder P; De Jong R; Lilien M; Donckerwolcke R; Groothof J
Pediatr Nephrol; 2000 Jul; 14(7):701-6. PubMed ID: 10912546
[TBL] [Abstract][Full Text] [Related]
19. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
[TBL] [Abstract][Full Text] [Related]
20. Changes in bone matrix mineralization after growth hormone treatment in children and adolescents with chronic kidney failure treated by dialysis: a paired biopsy study.
Nawrot-Wawrzyniak K; Misof BM; Roschger P; Pańczyk-Tomaszewska M; Ziółkowska H; Klaushofer K; Fratzl-Zelman N
Am J Kidney Dis; 2013 May; 61(5):767-77. PubMed ID: 23465957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
